Clinical Study

Overexpression of an Immune Checkpoint (CD155) in Breast Cancer Associated with Prognostic Significance and Exhausted Tumor-Infiltrating Lymphocytes: A Cohort Study

Figure 5

Effects of CD155 expression on disease-free and overall survival. (a) Disease-free survival. (b) Overall survival.
(a)
(b)